Search Results for "biotech"

• 

  Biotechnology

  Why the Latest IPO Wave Won’t Be Won on Science Alone.

  IPO activity does more than unlock capitalIn the last cycle, the path to public markets was ...

  

  By Barrington James March 20th, 2026

• 

  Pharmaceutical, Biotechnology

  Celebrating Women in Life Sciences: Driving Discovery, Innovation and Change

  Scientific progress has always depended on bold ideas, but also on the people courageous eno...

  

  By Barrington James March 8th, 2026

• 

  The Diversity Gap in Life Sciences: Progress, Pressure, and the Talent Challenge Companies Can’t Ignore

  The life sciences industry exists to solve some of the world’s most complex problems. ...

  

  By Barrington James March 6th, 2026

• 

  Company News, Biotechnology, Consulting

  Delivering 3 Strategic Leaders for an Immunology & Inflammation Biotech

  A global biotech company specialising in Immunology and Inflammation was approaching a criti...

  

  By Barrington James February 16th, 2026

• 

  Biotechnology, Medical Device, CRO, Consulting

  Navigating 503B Outsourcing Trends and 2026 Outlook.

  The U.S. compounding landscape changed substantially when the United States Pharmacopeia (US...

  

  By Ethan Dumoulin February 10th, 2026

• 

  2025 in Review: Strategic Maturity in Life Sciences

  As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...

  

  By Barrington James December 16th, 2025

• 

  The True Cost of Error in Life Sciences

  The hidden leakage across R&D, regulatory and launchRecent headlines are leaving little ...

  

  By Kyle Nelson October 10th, 2025

• 

  Company News

  Regeneron’s $256M 23andMe Buy: 15M Genomes & R&D Benefits

  Regeneron Pharmaceuticals has agreed to acquire almost all of 23andMe’s business lines, whic...

  

  By Barrington James May 20th, 2025